VR

Vanshika Rana

Active Director Additional Director DIN 11119850
DIN 11119850 First appointment May 2025 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value •••• Premium profile

About Vanshika Rana

Data last updated:

Vanshika Rana is an Additional Director at Camy Drugs & Chemicals Private Limited (since 2025). The company operates in Trading. Camy Drugs & Chemicals Private Limited reported revenue of ₹72.4 Lakh (FY 2025).

DIN 11119850
Primary Designation Additional Director
Industry Trading
First Appointment 22 May 2025
Oldest Company Age 12 yrs
Largest company Camy Drugs & Chemicals Private Limited · ₹72.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director22 May 20252014₹72.4 Lakh (FY 2025)Active

Board colleagues of Vanshika Rana

NameDINCompanyDesignation
Aditya Rana11100262Camy Drugs & Chemicals Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Camy Drugs & Chemicals Private Limited
Premium access

Shareholding and investment profile for Vanshika Rana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vanshika Rana

Vanshika Rana currently holds 1 directorship: Camy Drugs & Chemicals Private Limited (Additional Director, since 22 May 2025, revenue ₹72.4 Lakh (FY 2025)).

Vanshika Rana was first appointed on 22 May 2025 as Additional Director at Camy Drugs & Chemicals Private Limited.

The current boards of Vanshika Rana's companies include Aditya Rana (Camy Drugs & Chemicals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available